Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Robert

Showing results (1-10 of 512) with videos related to

Pageof 52
Sort By:
ESMO Open|August 3, 2017
Concerning the article by Louveau <i>et al</i> "<i>Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor</i>"Caroline Robert
La Revue Du Praticien|March 22, 2014
[Skin cancer: the time for therapeutic revolution!]Caroline Robert
Bulletin Du Cancer|September 13, 2007
[Cutaneous side effects of antiangiogenic agents]Caroline Robert
Trends in Molecular Medicine|November 16, 2017
Checkpoint Blockade Plus Oncolytic Virus: A Hot Therapeutic Cancer StrategyCaroline Robert
Nature Communications|August 1, 2020
A decade of immune-checkpoint inhibitors in cancer therapyCaroline Robert
European Journal of Dermatology : EJD|January 1, 2003
Leukocyte trafficking in the skinCaroline Robert
Nature Medicine|November 8, 2018
Is earlier better for melanoma checkpoint blockade?Caroline Robert
Nature Cancer|February 5, 2022
LAG-3 and PD-1 blockade raises the bar for melanomaCaroline Robert
Presse Medicale (Paris, France : 1983)|March 19, 2026
Quarterly Medical Review - Adverse Events of Cancer Immunotherapy - EditorialCaroline Robert
Bulletin Du Cancer|June 2, 2012
[Major therapeutic advances in the treatment of metastatic melanoma]Christine Mateus, Caroline Robert
Pageof 52

Showing results (1-10 of 512) with videos related to

Sort By:
Pageof 52
ESMO Open|August 3, 2017
Concerning the article by Louveau <i>et al</i> "<i>Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor</i>"Caroline Robert
La Revue Du Praticien|March 22, 2014
[Skin cancer: the time for therapeutic revolution!]Caroline Robert
Bulletin Du Cancer|September 13, 2007
[Cutaneous side effects of antiangiogenic agents]Caroline Robert
Trends in Molecular Medicine|November 16, 2017
Checkpoint Blockade Plus Oncolytic Virus: A Hot Therapeutic Cancer StrategyCaroline Robert
Nature Communications|August 1, 2020
A decade of immune-checkpoint inhibitors in cancer therapyCaroline Robert
European Journal of Dermatology : EJD|January 1, 2003
Leukocyte trafficking in the skinCaroline Robert
Nature Medicine|November 8, 2018
Is earlier better for melanoma checkpoint blockade?Caroline Robert
Nature Cancer|February 5, 2022
LAG-3 and PD-1 blockade raises the bar for melanomaCaroline Robert
Presse Medicale (Paris, France : 1983)|March 19, 2026
Quarterly Medical Review - Adverse Events of Cancer Immunotherapy - EditorialCaroline Robert
Bulletin Du Cancer|June 2, 2012
[Major therapeutic advances in the treatment of metastatic melanoma]Christine Mateus, Caroline Robert
Pageof 52